000 | 01762 a2200505 4500 | ||
---|---|---|---|
005 | 20250513134457.0 | ||
264 | 0 | _c19980309 | |
008 | 199803s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1002/hep.510270201 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBergquist, A | |
245 | 0 | 0 |
_aRisk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cFeb 1998 |
||
300 |
_a311-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAlcohol Drinking |
650 | 0 | 4 |
_aAlkaline Phosphatase _xanalysis |
650 | 0 | 4 |
_aBile Duct Neoplasms _xcomplications |
650 | 0 | 4 |
_aBile Ducts _xpathology |
650 | 0 | 4 |
_aBile Ducts, Intrahepatic _xpathology |
650 | 0 | 4 |
_aBilirubin _xanalysis |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xcomplications |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aCholangiocarcinoma _xcomplications |
650 | 0 | 4 |
_aCholangitis, Sclerosing _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGallbladder Neoplasms _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xcomplications |
650 | 0 | 4 |
_aLiver Diseases _xmortality |
650 | 0 | 4 |
_aLiver Neoplasms _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSmoking |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aGlaumann, H | |
700 | 1 | _aPersson, B | |
700 | 1 | _aBroomé, U | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 27 _gno. 2 _gp. 311-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.510270201 _zAvailable from publisher's website |
999 |
_c9431602 _d9431602 |